Acupuncture as another treatment option for women who have Pain in the belly foot and Muscle Pain in the belly that did not improve with the Injection of Anesthetic at the pain site

Not Applicable

• Conditions: Myofascial pain syndromes, pelvic pain; C05.651.550; C23.888.592.612.944

• Registration Number: RBR-4y8vd2
• Lead Sponsor: Faculdade de Medicina de Ribeirão Preto / Universidade de São Paulo - FMRP/USP

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2017-06-19
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Data analysis completed
• Sex: Female
• Target Recruitment: Not specified

Inclusion Criteria

Women with diagnostic criteria for chronic pelvic pain secondary to abdominal myofascial syndrome; Presence of only one active trigger point on the abdominal wall, have not undergone previous treatment with topical injectable block or acupuncture, age above 18 years and premenopausal, visual analogue scale with a value above 4.4 (moderate pain)

Exclusion Criteria

Women with anticoagulation or hemorrhagic disorders, local or systemic infections; Allergy to anesthetics, acute muscle trauma, extreme fear of needles; History of complaints of chronic musculoskeletal pain such as fibromyalgia, chronic fatigue or diabetes; Aspirin intake within 3 days after injection; All patients with suspected endometriosis, interstitial cystitis, irritable bowel syndrome, or other disease that warrants or contributes to chronic pelvic pain; Endometrioma or hernia evidenced by ultrasound of the abdominal wall, infections of the abdominal wall, lack after the beginning of the treatment

Study & Design

• Study Type: Intervention
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Primary outcome: decreased pain perception through the Visual Analogue Scale, Numerical Categorical Scale, McGill Pain and Algometry Questionnaire with a pressure manometer based on a significance level of 5% in pre and 1 week, 1 month , 3 months and 6 months after the interventions.;There was a reduction in the perception of pain in the participants of this study through analysis of the visual analog scale, numerical categorical scale and McGill questionnaire, and there was a correlation between these analyzed variables. At the algometry examination there was no reduction in the perception of statistically significant pain.

Secondary Outcome Measures

Name	Time	Method
Secondary outcome: quality of life measurement using the SF-36 questionnaire and anxiety and depression risk assessment using the hospital scale of anxiety and depression (HAD), based on a 5% level of significance in the pre and 1 measurements Week, 1 month, 3 months and 6 months after the interventions.;There was no statistically significant change in the aspects related to quality of life or risk for anxiety and depression in the study participants for both groups.